Structural basis for the functional properties of the P2X7 receptor for extracellular ATP

被引:41
作者
Jiang, Lin-Hua [1 ]
Caseley, Emily A. [1 ,2 ]
Muench, Steve P. [1 ]
Roger, Sebastien [3 ]
机构
[1] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England
[2] St James Univ Hosp, Fac Med & Hlth, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[3] Univ Tours, Fac Med, EA4245, Transplantat Immunol & Inflammat, Tours, France
基金
英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
Agonist binding; Receptor activation; Ion permeation; Large pore formation; Antagonism; AMINO-ACID-RESIDUES; P2X(7) RECEPTOR; ION-CHANNEL; PHARMACOLOGICAL CHARACTERIZATION; DIFFERENTIAL SENSITIVITY; IDENTIFICATION; ANTAGONISTS; BINDING; RAT; ACTIVATION;
D O I
10.1007/s11302-021-09790-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The P2X7 receptor, originally known as the P2Z receptor due to its distinctive functional properties, has a structure characteristic of the ATP-gated ion channel P2X receptor family. The P2X7 receptor is an important mediator of ATP-induced purinergic signalling and is involved the pathogenesis of numerous conditions as well as in the regulation of diverse physiological functions. Functional characterisations, in conjunction with site-directed mutagenesis, molecular modelling, and, recently, structural determination, have provided significant insights into the structure-function relationships of the P2X7 receptor. This review discusses the current understanding of the structural basis for the functional properties of the P2X7 receptor.
引用
收藏
页码:331 / 344
页数:14
相关论文
共 81 条
[11]   The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease [J].
Bartlett, Rachael ;
Stokes, Leanne ;
Sluyter, Ronald .
PHARMACOLOGICAL REVIEWS, 2014, 66 (03) :638-675
[12]   Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders [J].
Bhattacharya, Anindya .
FRONTIERS IN PHARMACOLOGY, 2018, 9
[13]   The Microglial ATP-Gated Ion Channel P2X7 As a CNS Drug Target [J].
Bhattacharya, Anindya ;
Biber, Knut .
GLIA, 2016, 64 (10) :1772-1787
[14]   Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567 [J].
Bhattacharya, Anindya ;
Wang, Qi ;
Ao, Hong ;
Shoblock, James R. ;
Lord, Brian ;
Aluisio, Leah ;
Fraser, Ian ;
Nepomuceno, Diane ;
Neff, Robert A. ;
Welty, Natalie ;
Lovenberg, Timothy W. ;
Bonaventure, Pascal ;
Wickenden, Alan D. ;
Letavic, Michael A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (03) :624-640
[15]   Mapping the Site of Action of Human P2X7 Receptor Antagonists AZ11645373, Brilliant Blue G, KN-62, Calmidazolium, and ZINC58368839 to the Intersubunit Allosteric Pocket [J].
Bin Dayel, Anfal ;
Evans, Richard J. ;
Schmid, Ralf .
MOLECULAR PHARMACOLOGY, 2019, 96 (03) :355-363
[16]   Residues 155 and 348 Contribute to the Determination of P2X7 Receptor Function via Distinct Mechanisms Revealed by Single-nucleotide Polymorphisms [J].
Bradley, Helen J. ;
Baldwin, Jocelyn M. ;
Goli, G. Ranjan ;
Johnson, Brian ;
Zou, Jie ;
Sivaprasadarao, Asipu ;
Baldwin, Stephen A. ;
Jiang, Lin-Hua .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (10) :8176-8187
[17]   P2X7 Receptor Channels Allow Direct Permeation of Nanometer-Sized Dyes [J].
Browne, Liam E. ;
Compan, Vincent ;
Bragg, Laricia ;
North, R. Alan .
JOURNAL OF NEUROSCIENCE, 2013, 33 (08) :3557-3566
[18]   New structure enlivens interest in P2X receptors [J].
Browne, Liam E. ;
Jiang, Lin-Hua ;
North, R. Alan .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (05) :229-237
[19]   IS THERE A BASIS FOR DISTINGUISHING 2 TYPES OF P2-PURINOCEPTOR [J].
BURNSTOCK, G ;
KENNEDY, C .
GENERAL PHARMACOLOGY, 1985, 16 (05) :433-440
[20]   Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future [J].
Burnstock, Geoffrey .
BIOESSAYS, 2012, 34 (03) :218-225